Published in Cancer Weekly, January 29th, 2008
"In our study all benign cases were negative for p16(INK4a), while more than half of the high grade lesions showed moderate or strong...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.